Posted in | News | Nanomaterials | Nanoanalysis

NIMS and NanoNextNL Enter Comprehensive Collaborative Agreement

NanoNextNL is a consortium of more than one hundred Dutch companies, universities, knowledge institutes and university medical centers, which is aimed at industry driven research into micro and nanotechnology.

Meeting at “nano tech 2013” between the executives from both sides. (from left, Mr. Paul op den Brouw, Innovatie Attaché from Dutch Embassy, Business Director Mr. Dick Koster, Dr. Johsei Nagakawa, Deputy General Manager of Academic Collaboration, President Sukekatsu Ushioda, Vice President Prof. Fred van Keulen, Dr. Masakazu Aono, Director General of MANA, and Executive Vice President Dr. Junichi Sone)

The total investment involved for NanoNextNL in the period 2010-2016 is 250 million euros, half of which is contributed by the Government of the Netherlands.

The CCA was prepared following building on contacts established during several visits and meetings in recent years. Early this year a NanoNextNL delegation headed by Vice President Prof. A. van Keulen and Business Director Mr. D. Koster visited NIMS and in turn received a NIMS delegation headed by Prof. S. Ushioda on the NanoNextNL booth during the nano tech 2013 exhibition.

Meanwhile, a comparison of the NIMS and NanoNextNL research program has revealed the “hot spots” in the available matching activities and interest. Both sides are now discussing to pursuit the promising possibilities envisaged in the agreed collaboration. As a first step plans are made for a follow up workshop early 2014 with mutual representatives who are active in the hot spot areas, following which exchange of researchers is foreseen later that year.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.